| Preface | 6 |
|---|
| Contents | 8 |
|---|
| Contributors | 10 |
|---|
| Part I: The Aging of Bone and Etiologies of Fractures | 14 |
|---|
| Chapter 1: Osteobiology of Aging | 15 |
| 1.1 Introduction | 15 |
| 1.2 Basic Anatomy of Bone | 16 |
| 1.2.1 Bony Matrix | 16 |
| 1.2.2 Cortical Bone | 16 |
| 1.2.3 Trabecular Bone | 17 |
| 1.3 Basic Multicellular Units | 17 |
| 1.3.1 Osteoclasts | 18 |
| 1.3.2 Osteoblasts | 18 |
| 1.3.2.1 Osteoblast Versus Adipocyte Differentiation | 21 |
| 1.3.3 Osteocytes | 22 |
| 1.4 Bone as a Mineral Reservoir | 22 |
| 1.5 Skeletal Maintenance and Remodeling | 23 |
| 1.5.1 Activation (Phase 1) | 23 |
| 1.5.1.1 Osteoprotegerin/RANK/RANKL | 23 |
| 1.5.2 Resorption (Phase 2) | 24 |
| 1.5.3 Reversal (Phase 3) | 24 |
| 1.5.4 Formation (Phase 4) | 25 |
| 1.6 Regulation of Bone Remodeling | 26 |
| 1.6.1 Vitamin D and Osteomalacia | 26 |
| 1.6.1.1 Vitamin D and Aging | 26 |
| 1.6.1.2 Vitamin D-Related Myopathy | 27 |
| 1.6.1.3 Vitamin D and Risk of Falls and Fracture | 27 |
| 1.6.2 Parathyroid Hormone and Secondary Hyperparathyroidism | 27 |
| 1.6.3 Gonadal Hormones | 28 |
| 1.6.4 Thyroid Hormone | 29 |
| 1.6.5 Growth Hormone/Insulin-Like Growth Factors | 29 |
| 1.6.6 Interleukins | 30 |
| 1.6.7 Calcitonin | 30 |
| 1.6.8 Fibroblast Growth Factors and Transforming Growth Factor-b | 30 |
| 1.7 The Pathophysiology of Bone Loss in the Elderly | 31 |
| 1.7.1 Age-Related Bone Loss | 31 |
| 1.7.2 Postmenopausal Osteoporosis | 32 |
| 1.7.3 Somatopause | 33 |
| 1.7.4 Androgen Decline in the Aging Male Syndrome and Andropause | 34 |
| 1.7.5 Renal Osteodystrophy | 35 |
| 1.7.6 Skeletal Unloading/Immobilization | 36 |
| 1.7.7 Tobacco- and Alcohol-Related Bone Loss | 37 |
| 1.7.8 Drug-Induced Osteoporosis | 38 |
| 1.7.8.1 Glucocorticoid-Induced Osteoporosis | 39 |
| 1.8 Cellular Senescence | 40 |
| 1.8.1 Telomere Shortening and Telomerase Dysfunction in Aging Bone | 42 |
| References | 42 |
| Chapter 2: Pathologic Fractures | 55 |
| 2.1 Introduction | 55 |
| 2.2 Metastatic Tumors of Bone | 56 |
| 2.2.1 Location | 56 |
| 2.2.2 Presentation | 56 |
| 2.2.3 Diagnostic Laboratory Tests | 57 |
| 2.2.4 Imaging | 57 |
| 2.2.5 Management Options | 59 |
| 2.2.5.1 Medical/Radiation Therapy | 59 |
| 2.2.5.2 Surgery | 60 |
| Indications | 60 |
| Treatment Options | 61 |
| Postoperative Care | 61 |
| 2.3 Multiple Myeloma | 63 |
| 2.3.1 Presentation | 63 |
| 2.3.2 Diagnostic Laboratory Tests | 63 |
| 2.3.3 Imaging | 63 |
| 2.3.4 Management Options | 64 |
| 2.3.4.1 Medical Therapy | 64 |
| 2.3.4.2 Surgery | 64 |
| Surgical Treatment Options | 64 |
| Postoperative | 65 |
| References | 65 |
| Chapter 3: Falls | 66 |
| 3.1 Introduction | 66 |
| 3.2 Epidemiology | 67 |
| 3.3 Risk Factors and Screening | 67 |
| 3.4 Fall Assessment | 68 |
| 3.4.1 Post-fall Assessment and Evaluation | 68 |
| 3.4.1.1 First Fall | 68 |
| 3.4.1.2 Recurrent Falls | 69 |
| 3.5 Fall Prevention | 70 |
| 3.5.1 Primary Prevention | 70 |
| 3.5.1.1 Exercise | 70 |
| 3.5.1.2 Importance of Vitamin D | 71 |
| 3.5.1.3 Sarcopenia and Nutrition | 72 |
| 3.5.2 Secondary Prevention | 73 |
| 3.5.2.1 Technological Devices | 74 |
| 3.5.2.2 Hip Protectors | 74 |
| 3.5.2.3 Post-fall Interventions | 74 |
| 3.5.2.4 Community-based Older Adults | 75 |
| 3.5.2.5 Facility-based Older Adults | 76 |
| 3.5.2.6 Inpatient-Based Older Adult | 76 |
| 3.5.3 Tertiary Prevention | 77 |
| References | 77 |
| Part II: Perioperative Management | 80 |
|---|
| Chapter 4: Preoperative Assessment of Risk | 81 |
| 4.1 Introduction | 82 |
| 4.2 Risk Factors | 83 |
| 4.3 Risk Stratification | 84 |
| 4.4 Preoperative Cardiac Evaluation | 84 |
| 4.5 Preoperative Pulmonary Evaluation | 86 |
| 4.6 Infection and Perioperative Antibiotics | 87 |
| 4.7 Thromoembolic Risk | 87 |
| 4.8 Gastrointestinal Risks and Obesity | 88 |
| 4.9 Nutritional Risks | 88 |
| 4.10 Renal and Urological Complications | 90 |
| 4.11 Perioperative Management of Diabetes Mellitus | 91 |
| 4.12 Neurological Risk | 91 |
| 4.13 Assessment of Functional Status | 92 |
| 4.14 Unnecessary Preoperative Testing | 93 |
| References | 94 |
| Chapter 5: Anticoagulation | 97 |
| 5.1 Introduction | 97 |
| 5.2 Pharmacologic Methods of Prophylaxis | 98 |
| 5.2.1 Aspirin | 98 |
| 5.2.2 Vitamin K Antagonists (Warfarin) | 100 |
| 5.2.3 Heparins | 101 |
| 5.2.4 Fondaparinux | 103 |
| 5.3 Timing and Duration of Prophylaxis | 104 |
| 5.4 Risks of Anticoagulation | 104 |
| 5.4.1 Heparin-Induced Thrombocytopenia | 105 |
| 5.5 Nonpharmacologic Methods of Prophylaxis | 105 |
| 5.5.1 Inferior Vena Caval Filters | 107 |
| References | 108 |
| Chapter 6: Prevention and Management of Perioperative Delirium | 111 |
| 6.1 Background | 111 |
| 6.1.1 Significance of Delirium in Elderly Patients with Fractures | 111 |
| 6.1.2 Recognizing Delirium | 113 |
<